The synergistic effects of saxagliptin and metformin on CD34+ endothelial progenitor cells in early type 2 diabetes patients: a randomized clinical trial

AIMS: Type 2 diabetes is associated with endothelial dysfunction leading to cardiovascular disease. CD34+ endothelial Progenitor Cells (EPCs) are responsible for endothelial repair and neo-angiogenesis and can be used as a cardiovascular disease risk biomarker. This study investigated whether the ad...

Descripción completa

Detalles Bibliográficos
Autores principales: Dore, Fiona J., Domingues, Cleyton C., Ahmadi, Neeki, Kundu, Nabanita, Kropotova, Yana, Houston, Sara, Rouphael, Carol, Mammadova, Aytan, Witkin, Linda, Khiyami, Anamil, Amdur, Richard L., Sen, Sabyasachi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934787/
https://www.ncbi.nlm.nih.gov/pubmed/29724198
http://dx.doi.org/10.1186/s12933-018-0709-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934787/
https://www.ncbi.nlm.nih.gov/pubmed/29724198
http://dx.doi.org/10.1186/s12933-018-0709-9

Ejemplares similares